TABLE 2.
Acceptability of BEP supplements at Week 4 and Week 8
| Lipid‐based peanut paste | Vanilla biscuit | |||||
|---|---|---|---|---|---|---|
| All (n = 80) | Group 1 (n = 40) | Group 2 (n = 40) | All (n = 80) | Group 1 (n = 40) | Group 2 (n = 40) | |
| Appreciation of supplement (1 = I dislike it very much to 7 = I like it very much), median (Q1–Q3) | ||||||
| Colour | 7 (6–7) | 7 (7–7) | 7 (6–7) | 7 (6–7) | 7 (6–7) | 7 (7–7) |
| Taste | 6 (6–7) | 6 (6–7) | 6 (6–7) | 7 (6–7) | 7 (6–7) | 6.75 (7–7) |
| Texture/consistency | 6 (6–7) | 6 (5–7) | 6.5 (6–7) | 7 (6–7) | 7 (6–7) | 7 (6–7) |
| Smell | 6 (3–7) | 6 (3.75–7) | 5.5 (2–7) | 7 (6–7) | 7 (6–7) | 7 (7–7) |
| Overall appreciation | 6 (5–7) | 6 (5–7) | 6 (5–7) | 7 (6–7) | 7 (6–7) | 7 (6.75–7) |
| Perceived child likeability | 7 (6–7) | 7 (6–7) | 7 (6–7) | 7 (6–7) | 7 (7–7) | 6.5 (6–7) |
| Perceived adult likeability | 6 (5–7) | 6 (5–6.75) | 6 (5–7) | 6 (4–7) | 6 (6–7) | 6 (4–7) |
| Perception of supplement use (1 = I don't agree at all to 7 = I agree completely), median (Q1–Q3) | ||||||
| Supplement is convenient to eat | 6 (6–7) | 6 (6–7) | 6.5 (6–7) | 7 (6.75–7) | 7 (6–7) | 7 (7–7) |
| Supplement is convenient to eat between meals | 6 (5–7) | 6 (5.75–7) | 6 (4.75–7) | 6 (5–7) | 6 (6–7) | 6 (5–7) |
| Supplement is medicine | 6 (3.75–6) | 5 (3–6) | 6 (5–7) | 6 (5–7) | 6 (4.5–7) | 7 (5–7) |
| Feel full after full portion | 5 (3–6) | 5 (3–6) | 5 (3–6) | 5 (3–6.25) | 5 (3–6) | 6 (5–7) |
| Would share with others | 1 (1–2.25) | 1 (1–2) | 2 (1–3) | 1 (1–3) | 1 (1–2) | 1 (1–3.25) |
| Willingness to use daily for 12 months (1 = I don't agree at all to 7 = I agree completely), median (Q1–Q3) | ||||||
| Would use if provided | 7 (6–7) | 6.5 (6–7) | 7 (6–7) | 7 (6–7) | 7 (6–7) | 7 (6.75–7) |
| Would use if purchased | 5 (3–7) | 5 (3.75–7) | 6 (3–7) | 6 (4–7) | 5.5 (5–7) | 6 (3–7) |
| Would pay how much, per daily dose (CFA) a , n (%) | ||||||
| 0–100 | 47 (58.7) | 24 (60) | 23 (57.5) | 58 (72.5) | 30 (75) | 28 (70) |
| 101–200 | 16 (20) | 8 (20) | 8 (20) | 13 (16.3) | 7 (17.5) | 6 (15) |
| 201–300 | 3 (3.8) | 1 (2.5) | 2 (5) | 5 (6.2) | 1 (2.5) | 4 (10) |
| 301–400 | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| 401–500 | 6 (7.5) | 5 (12.5) | 1 (2.5) | 2 (2.5) | 2 (5) | 0 (0) |
| >500 | 1 (1.3) | 0 (0) | 1 (2.5) | 0 (0) | 0 (0) | 0 (0) |
| Do not know | 7 (8.7) | 2 (5) | 5 (12.5) | 2 (2.5 | (0) | 2 (5) |
| Acceptability of portion size (for a snack), n (%) | ||||||
| Portion size is acceptable | 75 (93.8) | 37 (92.5) | 38 (95) | 72 (90) | 37 (92.5) | 35 (87.5) |
| Too small | 1 (1.2) | 1 (2.5) | 0 | 3 (3.8) | 2 (5) | 1 (2.5) |
| Too big | 4 (5) | 2 (5) | 2 (5) | 5 (6.2) | 1 (2.5) | 4 (10) |
| Preference for continuation of consumption during pregnancy and during the breast‐feeding period at Week 8, n (%) | ||||||
| Choice of supplement | 32 (40) | 11 (27.5) | 21 (52.5) | 48 (60) | 29 (72.5) | 19 (47.5) |
a
The exchange rate for CFA during the study period was between 0.0017 and 0.0018 to 1 USD, retrieved from: www.OANDA.com.